Results 171 to 180 of about 4,373 (200)
Some of the next articles are maybe not open access.
Treatment in Lambert–Eaton myasthenic syndrome
Annals of the New York Academy of Sciences, 2012Besides antitumor therapy for patients with the paraneoplastic form of Lambert–Eaton myasthenic syndrome (LEMS), the mainstay of symptomatic treatment in LEMS is 3,4‐diaminopyridine (3,4‐DAP). Data from four randomized, placebo‐controlled trials have revealed that muscle strength scores increased significantly with 3,4‐DAP.
openaire +2 more sources
Lambert–Eaton Myasthenic Syndrome
Journal of Neuro-Ophthalmology, 2016To evaluate ocular signs and symptoms in Lambert-Eaton myasthenic syndrome (LEMS) and determine the frequency of ophthalmic involvement.A retrospective review of the medical records of all patients diagnosed with LEMS at the Mayo Clinic in Rochester, MN, from January, 1976, to December, 2010, was performed with special attention to ophthalmic symptoms ...
Jeffery D, Young, Jacqueline A, Leavitt
openaire +2 more sources
Lambert–Eaton Myasthenic Syndrome
2017Lambert–Eaton myasthenic syndrome (LEMS) is an uncommon presynaptic disorder of the neuromuscular junction. It presents with progressive proximal weakness, depressed tendon reflexes and autonomic dysfunction. Electrophysiological triad of low amplitude motor potentials, decremental response on low rate repetitive nerve stimulation (RNS) and increment ...
Satish V. Khadilkar +2 more
openaire +1 more source
[Lambert-Eaton myasthenic syndrome].
Brain and nerve = Shinkei kenkyu no shinpo, 2011Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease of the neuromuscular junction, and approximately 60% of patients with LEMS have a tumor, mostly small cell lung cancer (SCLC), as a paraneoplastic neurological syndrome. The clinical data of Japanese patients in the present study are as follows: the ratio of men to women is 3: 1 (mean ...
Masakatsu, Motomura, Taku, Fukuda
openaire +1 more source
The Lambert-Eaton Myasthenic Syndrome
Clinical Reviews in Allergy & Immunology, 2001A F, Carpentier, J Y, Delattre
openaire +2 more sources
Lambert–Eaton Myasthenic Syndrome Plus
Journal of Clinical Neuromuscular Disease, 2019Costa, Mariana R. +2 more
openaire +2 more sources
Pediatric Lambert-Eaton Myasthenic Syndrome
Minerva Pediatrics, 2017Jorge A, Avina Fierro +1 more
openaire +2 more sources
The exhaustibility of Lambert-Eaton myasthenic syndrome
Clinical Neurophysiology, 2014Papathanasiou, Eleftherios S. +1 more
openaire +2 more sources
Amifampridine for the Management of Lambert-Eaton Myasthenic Syndrome: A New Take on an Old Drug
Annals of Pharmacotherapy, 2020Connie H Yoon, Adam Smith
exaly

